Anti-tumor necrosis factor-α therapy and paradoxical autoimmunity in inflammatory bowel disease: a need for risk-aware monitoring

Intestinal Research · Published 2026-07-29 · DOI 10.5217/ir.2026.00169

Free full text

Authors (1)

Ji Eun Kim

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kim, J. (2026). Anti-tumor necrosis factor-α therapy and paradoxical autoimmunity in inflammatory bowel disease: a need for risk-aware monitoring. Intestinal Research. https://doi.org/10.5217/ir.2026.00169

Related articles

• Association between anti-tumor necrosis factor alpha exposure and new-onset autoimmune diseases in inflammatory bowel disease: a nationwide case-control study in Korea · Intestinal Research · 2026 · Same journal
• Tofacitinib in older patients with ulcerative colitis: balancing efficacy and safety · Intestinal Research · 2026 · Same journal
• The JAK attack: transforming the management of ulcerative colitis in India · Intestinal Research · 2025 · Same journal
• Real-world effectiveness and safety of upadacitinib in Korean patients with inflammatory bowel disease: a single-center retrospective study · Intestinal Research · 2026 · Same journal
• One-year effectiveness and safety of ustekinumab treatment in patients with ulcerative colitis: an Asan-Crohn’s and Colitis Association in Daegu-Gyeongbuk (CCAiD) multicenter real-world cohort study · Intestinal Research · 2026 · Same journal
• Analysis of gut microbiota in super donors for fecal microbiota transplantation and isolated gut commensal bacteria of inhibition against Clostridioides difficile · Intestinal Research · 2026 · Same journal
• Safety and effectiveness of budesonide rectal foam for ulcerative colitis in a large-scale, multicenter, prospective observational study: final report of post-marketing surveillance in Japan · Intestinal Research · 2026 · Same journal
• Preventive and therapeutic effects of co-administration of Bacteroides thetaiotaomicron and infliximab on dextran sodium sulfate-induced colitis in mice · Intestinal Research · 2025 · Same journal
• Real-world use and perceptions of advanced combined therapies in treating inflammatory bowel disease · Intestinal Research · 2026 · Same journal
• Appropriate J-pouch volume associated with improved clinical outcomes and long-term quality of life in patients with ulcerative colitis after ileal pouch-anal anastomosis: results from China UC Pouch Center Union · Intestinal Research · 2026 · Same journal